JPS606617A - 抗菌性組成物 - Google Patents

抗菌性組成物

Info

Publication number
JPS606617A
JPS606617A JP8060683A JP8060683A JPS606617A JP S606617 A JPS606617 A JP S606617A JP 8060683 A JP8060683 A JP 8060683A JP 8060683 A JP8060683 A JP 8060683A JP S606617 A JPS606617 A JP S606617A
Authority
JP
Japan
Prior art keywords
acid
antibacterial agent
lactam antibiotic
group
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8060683A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0373523B2 (https=
Inventor
Tsutomu Irikura
勉 入倉
Keiji Hirai
敬二 平井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Priority to JP8060683A priority Critical patent/JPS606617A/ja
Publication of JPS606617A publication Critical patent/JPS606617A/ja
Publication of JPH0373523B2 publication Critical patent/JPH0373523B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP8060683A 1983-05-09 1983-05-09 抗菌性組成物 Granted JPS606617A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8060683A JPS606617A (ja) 1983-05-09 1983-05-09 抗菌性組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8060683A JPS606617A (ja) 1983-05-09 1983-05-09 抗菌性組成物

Publications (2)

Publication Number Publication Date
JPS606617A true JPS606617A (ja) 1985-01-14
JPH0373523B2 JPH0373523B2 (https=) 1991-11-22

Family

ID=13722986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8060683A Granted JPS606617A (ja) 1983-05-09 1983-05-09 抗菌性組成物

Country Status (1)

Country Link
JP (1) JPS606617A (https=)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767762A (en) * 1985-12-23 1988-08-30 Abbott Laboratories Tricyclic quinoline and naphthyride antibacterials
JPH01308281A (ja) * 1987-08-31 1989-12-12 Dainippon Pharmaceut Co Ltd 三環式化合物、そのエステルおよびその塩
WO1991016327A1 (en) 1990-04-18 1991-10-31 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactams
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
US5387748A (en) * 1988-10-24 1995-02-07 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial dithiocarbamoyl quinolones
US5434147A (en) * 1988-10-24 1995-07-18 Proctor & Gamble Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
US5491139A (en) * 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
US5637580A (en) * 1988-10-24 1997-06-10 The Procter & Gamble Company Antimicrobial penem-quinolones
KR100295742B1 (ko) * 1999-04-16 2001-07-03 이동규 동물용 복합항생제 조성물

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767762A (en) * 1985-12-23 1988-08-30 Abbott Laboratories Tricyclic quinoline and naphthyride antibacterials
JPH01308281A (ja) * 1987-08-31 1989-12-12 Dainippon Pharmaceut Co Ltd 三環式化合物、そのエステルおよびその塩
US5648346A (en) * 1988-10-24 1997-07-15 The Procter & Gamble Company Antimicrobial carbacephem-quinolones
US5631256A (en) * 1988-10-24 1997-05-20 The Procter & Gamble Company Antimicrobial quinolone thioureas
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
US5387748A (en) * 1988-10-24 1995-02-07 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial dithiocarbamoyl quinolones
US5434147A (en) * 1988-10-24 1995-07-18 Proctor & Gamble Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
US5491139A (en) * 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
US5672600A (en) * 1988-10-24 1997-09-30 The Procter & Gamble Company Antimicrobial dithiocarbamoyl quinolones
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
US5637580A (en) * 1988-10-24 1997-06-10 The Procter & Gamble Company Antimicrobial penem-quinolones
US5646139A (en) * 1988-10-24 1997-07-08 The Procter & Gamble Company Antimicrobial carbapenem quinolones
US5656623A (en) * 1988-10-24 1997-08-12 The Procter & Gamble Company Antimicrobial lactam-quinolones
WO1991016327A1 (en) 1990-04-18 1991-10-31 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactams
US5530116A (en) * 1990-04-18 1996-06-25 The Procter & Gamble Company Antimicrobial quinolonyl lactams
KR100295742B1 (ko) * 1999-04-16 2001-07-03 이동규 동물용 복합항생제 조성물

Also Published As

Publication number Publication date
JPH0373523B2 (https=) 1991-11-22

Similar Documents

Publication Publication Date Title
US4956179A (en) Antibacterial combination of penicillin and cephalosporin
Smith The mode of action of 4-quinolones and possible mechanisms of resistance
Aswapokee et al. A sulfone β-lactam compound which acts as a β-lactamase inhibitor
Casewell et al. In-vitro activity of mupirocin (‘pseudomonic acid’) against clinical isolates of Staphylococcus aureus
CN103687598B (zh) 包括舒巴坦和β-内酰胺酶抑制剂的药物组合物
CN105246476B (zh) 含噁唑烷酮-喹诺酮的联合疗法在治疗细菌感染中的应用
WO2000068229A3 (en) (s)-benzoquinolizine carboxylic acids and their use as antibacterial agents
DE19652239A1 (de) Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
JP5470245B2 (ja) バイオフィルム形成の処置のためのトリアゾール化合物
JP2001503411A (ja) 抗生物質耐性感染症の処置のための化合物、組成物および方法
JPS606617A (ja) 抗菌性組成物
Ball Overview of clinical experience with ciprofloxacin
Mitsuhashi Drug resistance in bacteria: history, genetics and biochemistry
US20060073156A1 (en) Fosfomycin and n-acetylcysteine for the treatment of biofilms caused by escheric ia coli and other pathogens of the urinary tract
CH642850A5 (it) Composizioni farmaceutiche ad attivita antibatterica contro infezioni da germi gram-positivi e gram-negativi.
JPH0717609B2 (ja) ノルフロキサシンの水溶性付加物
Van Landuyt et al. Comparative activity of BRL 25.000 with amoxycillin against resistant clinical isolates
Martin et al. The use of fluoroquinolones in the treatment of skin infections
Aldridge et al. Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi
US9265744B2 (en) Fulvic acid and antibiotic combination for the inhibition or treatment of multi-drug resistant bacteria
Takahata et al. In-vitro and in-vivo activities of T-3262, a new pyridone carboxylic acid
Jackson et al. Sodium clavulanate potentiation of cephalosporin activity against clinical isolates of cephalothin-resistant Klebsiella pneumoniae
EP0203559A1 (en) Penicillin derivative containing naphthyridine
CN115969823B (zh) β-内酰胺酶抑制剂
Arguedas et al. In vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputum